This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
26-28 Feb, 2025
Westin Miyako KyotoKyoto, Japan

Dr. Hitoshi Kuroda, PhD
Business Development at StemRIM
Speaker

Profile

Dr. Hitoshi Kuroda started his career as a patent attorney in a patent firm in Tokyo. After that, he entered a graduate program at Louisiana State University Health Sciences Center, New Orleans and obtained Ph.D. in neuroscience with his focus on gene delivery to the brain. (Unlike today, the most popular gene delivery vehicle at that time was viral vectors. He thinks lipid nanoparticles (LNPs) are more advantageous now.) After finishing the graduate school, he joined a law firm in San Diego and dealt with various patent matters including prosecution, litigation and licensing. In 2020, he joined StemRIM Inc. as an in-house patent attorney and focused on patent portfolio strategy. Eventually his role had shifted, and now he is focusing on licensing, technology transfer and joint research. At TIDES Asia 2025, he will share the fascination of StemRIM’s lead product, TRIM4.